Neurology

CNS Pharmaceuticals Provides Clinical Trial Update for Ongoing Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

Company continued to see rapid progression and acceleration of enrollment with 180 patients enrolled to date across 46 clinical trial...

Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook

Favorable Motion Ruling in Xifaxan® Litigation Reinforces Continuing Salix Growth StrategyBalance Sheet Initiatives Further Enhance Liquidity ProfileContinued Evaluation of Optimal...

Imperative Care Announces NVQI Registry Data on the Real-World Performance of the Zoom Aspiration Catheters for Ischemic Stroke Treatment

 Late-Breaking Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Demonstrate High Rates of Successful Reperfusion and Rapid Procedure...

First-Ever BioMech Clinical Motion Lab Opens in Atlanta to Accelerate Traumatically Injured Patients’ Recovery using AI-driven Motion Science Technology in Clinic and at Home

BioMech, Atlanta's Independent Neurodiagnostic Clinic join forces to help patients and health care providers quantitatively measure and monitor function RICHMOND,...

Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases

– Kriya's therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of...

BPGbio and VELL Health Collaborate to Launch Revolutionary Global Health Initiative to Improve Type 2 Diabetes Outcomes in Guyana

Partnership supports Guyana’s launch of their Wellness Initiative to promote a healthier lifestyle among its citizensBOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading...

error: Content is protected !!